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Abstract
Background: The first stages of HIV-1 infection are essential to establish the diversity of virus population within host. It has
been suggested that adaptation to host cells and antibody evasion are the leading forces driving HIV evolution at the initial
stages of AIDS infection. In order to gain more insights on adaptive HIV-1 evolution, the genetic diversity was evaluated
during the infection time in individuals contaminated by the same viral source in an epidemic cluster. Multiple sequences of
V3 loop region of the HIV-1 were serially sampled from four individuals: comprising a single blood donor, two blood
recipients, and another sexually infected by one of the blood recipients. The diversity of the viral population within each
host was analyzed independently in distinct time points during HIV-1 infection.
Results: Phylogenetic analysis identified multiple HIV-1 variants transmitted through blood transfusion but the establishing
of new infections was initiated by a limited number of viruses. Positive selection (dN/dS.1) was detected in the viruses
within each host in all time points. In the intra-host viruses of the blood donor and of one blood recipient, X4 variants
appeared respectively in 1993 and 1989. In both patients X4 variants never reached high frequencies during infection time.
The recipient, who X4 variants appeared, developed AIDS but kept narrow and constant immune response against HIV-1
during the infection time.
Conclusion: Slowing rates of adaptive evolution and increasing diversity in HIV-1 are consequences of the CD4+ T cells
depletion. The dynamic of R5 to X4 shift is not associated with the initial amplitude of humoral immune response or
intensity of positive selection.
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Introduction
Intra-host HIV-1 diversity is highly affected by the intensity of
the antibody response against viral epitopes in the initial stages of
infection [1,2,3,4]. In addition, over the HIV-1 infection time, the
intensity of positive selection tends to decline [4] and the rate of
synonymous mutations usually increases [5]. It has been suggested
that selective pressure in HIV-1 is a direct function of CD4+ T
cells levels [6]. Additionally, the affinity of the virus by host cells is
equally important to determine rates of positive and purifying
selection in V3 loop of HIV-1 [7]. However other features of the
virus life cycle may equally affect the rate of adaptive evolution of
HIV-1 [8].
During the progress of HIV-1 infection in nearly half of
individuals the virus changes its chemokine receptor usage [9,10].
Usually, in the early phase of infection the HIV-1 has a tropism for
CCR5 (R5 variants), in the late phase of the infection viruses (X4
variants) that preferentially use CXC4 emerge. At the late phase of
HIV-1 infection, the intra-host viral population may be composed
exclusively by X4 variants, by variants able to use both coreceptor
(R5X4) or the viral population can be represent by similar
proportions of R5 and X4 variants [11,12]. In addition, R5 and
X4 viruses can even recombine in the course of intra-host HIV-1
infection [13]. These variants have distinct properties the
emergence of X4 variants is usually associated with a decline of
CD4 cells and rapid disease progression [10,14,15]. Therefore, it
has been suggested that X4 viruses might be more virulent than
R5 viruses. R5 can be isolated preferentially from CD4+ memory
T cells and X4 can be isolated from both memory and naı ¨ve cells
[16,17]. However, the reason for the change in the coreceptor
usage and why it is restricted to a few patients remains uncertain.
It has been suggested that R5 variants may have a selective
advantage because it has a higher replication rate in memory cells,
compared with naı ¨ve cells [18,19]. In addition, in resting CD4+ T
cells R5 variants, but not X4 variants, induce expression of genes
involved in cell proliferation, this might facilitate the replication of
R5 variants [20]. These findings might explain the predominance
of R5 in the early infection, but not the later emergence of X4
variants. Recently, it has been shown that the turnover between
naı ¨ve and memory cells might explain the switch from R5-to-X4
variants in late infection [21].
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response and the impact of R5-to-X4 shift evolution from the same
viral source in epidemic linked hosts. Thus to gain further insights
into the evolutionary HIV-1 within hosts, we evaluated sequences
from an epidemic cluster where the same viral source from a HIV-
infected donor contaminated two blood recipients. One of the
recipients infected, through sexual intercourse, her male partner
shortly after she received the contaminated blood transfusion. In
the blood donor and in one recipient, X4 viruses emerged
independently and the outcome of the virus dynamics in each
individual was also distinct. A detailed Bayesian analysis was
performed in molecular clones generated in distinct time points
from each individual of the epidemic cluster.
Results
Pairwise genetic diversity
Figure 1 shows the transmission cluster and genetic diversity at
distinct time points according to the sampling schedule of the
study. The blood donor (DO), a 30 years old male, evolved
without apparent clinical or immunological progression with a
stable CD4 in a follow up from 1985 to 1993. Interestingly, in
1987 a minority variant with GSGR tetramer at the tip of V3 loop
was detected in the DO sequences. In 1989 this GSGR variant
was majority (n=8) compared with the previous GPGR variant
(n=2). Between 1990 and 1991 a mix of GSGR (n=10) and
GPGR (n=6) variants was observed. Notably, in 1993 GSGR
variants were no longer detected in DO samples, concomitantly, in
this year we identified one X4 strain (filled circles in the Figure 1).
Genetic diversity was evaluated using pairwise distances. From
1985 to 1993 the mean diversity of DO sequences increased from
0.01560.004 to 0.05860.012, respectively. Since samples from
patient DO were composed by two distinct variants (viz., GSGR
and GPGR) we analyzed separately the genetic diversity of each
one. In 1987 two samples of GSGR variant was detected and their
genetic diversity was 0.00960.0046, whereas the diversity of
GPGR variants at this year was 0.01960.006. In 1989 GSGR
variants predominated in the samples (8 out 10 sequence) and had
mean diversity of 0.01760.004. Particularly, although in minority
(n=2) GPGR variants presented a high mean genetic diversity
(0.04060.009). On the other hand, between 1990 and 1991 there
was equilibrium of GSGR and GPGR sequences in the DO
samples. The genetic diversity of GSGR variants was maintained
at lower level of 0.01560.004 while the mean genetic diversity of
GPGR remained high at mean of 0.03960.013. In 1993 only
GPGR were detected and the mean genetic diversity equally
increased to 0.05860.012. Although GSGR prevailed in 1989 its
genetic diversity was always at lower levels in the interval between
1987 and 1991 (ranging from 0.009 to 0.015). In opposition,
GPGR variants presented a constant increasing diversity, even
when it in minority proportion (2 out 10) in 1989 (0.04060.009).
Notably, the fluctuation in the proportions of GSGR and GPGR
variants in the viral population of DO patient apparently were not
correlated with the genetic diversity, since the less divergent
GSGR viruses out-competed the GPGR lineage between 1989
and 1991.
The first recipient analyzed (RA) was a 57-year-old male that
received red blood cells from blood donor due to a bleeding
duodenal ulcer and also evolved with a stable CD4 without a
detectable emergency of X4 related strains from 1986 to 1991.
Sequences from RA individual obtained at the start of infection in
1986, revealed high genetic diversity with mean of 0.02660.006.
In this year, two phylogenetically distinct groups of sequences were
detected (see phylogenetic analysis), each one with similarly high
genetic diversity. The mean genetic diversity of 0.02660.009 was
detected in the first and the mean of 0.02360.005 was detected in
the second group. However, in 1987 the mean genetic diversity
decreased to 0.01460.004. Subsequently, in the following years
(1989 to 1991) HIV samples from patient RA increased
continuously its genetic diversity (Figure 1).
The second recipient analyzed (RB) was a female contaminated
by the same viral source (same blood donation) that was inoculated
in the recipient RA. RB was transfused in January 1985 at the age
of 20 year old with platelets due to a post-partum bleeding. The
mean genetic diversity of viral sequences from RB increased
continuously from 1986 to 1989, respectively 0.01760.005 to
0.06060.012. Then it decreased slightly to 0.03560.007 in 1990.
Coincidently RB maintained high counts of CD4+ T cells after her
infection in 1985 until 1989, then counts of CD4+ T cells
decreased deeply and she evolved to AIDS and death in 1990
(levels of the CD4+ T cell counts are shown in the Figure S1).
Notably, after X4-strains emerged in 1989 it persisted always as
minority in the viral population of RB during all course of
infection. In addition, pairwise distances of X4-strains sequences
showed a limited degree of genetic diversity, with mean of
0.01860.009 in 1989 and 0.01560.006 in 1990. Interestingly, the
emergence of X4-strains in the donor (DO) and recipient B (RB)
coincided with the high peak of overall pairwise diversity.
The male partner of RB was infected sexually by her and
evolved with a stable CD4 counts until 1990 with no detectable
X4-strains sequences. The genetic diversity of viral population of
the sexual partner (SC) was also limited in the start of infection in
1986 with mean of 0.01760.005. Then the mean genetic diversity
increased continuously until reach its high level of 0.04960.009 in
1990 (Figure 1).
Phylogenetic analysis
Maximum posteriori (MP) trees were constructed initially to
establish the relationship among the isolates of the donor and the
blood recipients. All sequences obtained within a certain patient
displayed an ordered pattern of time in the trees, according to
their dates. Time ordered trees, thus provide an evidence for no
recombination among variants within hosts. In addition, recom-
bination was also verified by other methods [22]. In the figure 2A,
the topology of the tree constructed with sequences of the donor
DO and the recipient RA revealed that viruses from the donor
(sequences indicated in magenta and green color) composed two
distinct phylogenetic clusters. One cluster included variants having
the GPGR motif at the V3 loop of the envelope gene. These
variants probably derived from the founder viruses that infected
the blood donor because isolates with GPGR were detected early
in 1985. The other cluster included variants with the GSGR motif
(green sequences in the Figure 2A) at the V3 loop and they
emerged late in 1987 (we removed the second amino acid from the
V3 loop tetramer). In addition, this tree also showed that the
sequences isolated before 1990 from the recipient RA (indicated in
orange color in the tree) intermingled with the sequences from the
donor. While, those sequences isolated in 1990 and 1991 probably
originated from same ancestors (highlighted in blue in the
Figure 2A). Consequently, although multiple variants were
transmitted to the blood recipient RA, quite few of them effectively
contributed to establish the new infection.
Likewise, the MP tree constructed with molecular clones from
the donor and the recipient RB (sequences indicated in blue color
in the Figure 2B) indicated that multiple clones were transmitted
through blood contamination. Particularly, the sequence
RB138_87 is only RB isolate related with GSGR viruses from
the donor. The tree also revealed that all clones generated from
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RB138_87, shared the same 1987 ancestor sequence. Therefore,
the viral population of RB expanded probably from few variants.
Notably, X4-variants (sequences indicated in red color in the
Figure 2B) emerged independently in the donor in 1993 and in the
recipient RB in 1989. Finally, the tree constructed to evaluate the
dynamic of sexual transmission using sequences of recipient RB
and sequences of the sexual partner (SC) revealed that the viral
population of the patient SC is completely monophyletic (Figure
S2).
Pattern of N-linked glycosilation
The pattern of N-linked glycosylation is mediated by humoral
immune escape antibody attack. There is a linear correlation
between infection time and the amount of glycosylation in the V3
loop of HIV-1 [23]. It has been shown that in the first phase of
HIV-1 infection the virus needs to bind and interact with cellular
receptors, then it has to reduce the number of glycosilated sites.
Conversely, HIV-1 evades antibody attack by the acquisition of
mutations at N-linked glycosylation sites. These mutations permit
the HIV to avoid binding of neutralizing antibodies to the viral
surface proteins, consequently virus to escape from the humoral
immune surveillance, this mechanism is better know as the
‘‘glycan-shield’’ [24]. We investigated the proportion of N-linked
glycosylation sites and found that in general the amount of
glycosylated sites increased in viruses isolated in the late stages of
HIV infection (clusters highlighted in the Figure S3). The
exceptions were X4 viruses in the recipient RB (red sequences in
the Figure S3) and GSGR viruses of the donor DO (highlighted in
cyan). Sites glycosylated in the initial viral sequences usually
remained unchanged during the infection, and new mutations
were not necessarily located in the same sites in all patients
(number within parenthesis in the Figure S3). The most radical
changes in the location of glycosylation sites were observed in the
intra-host viruses of the recipient RB (sequences depicted in blue
and red colors in the Figure S3).
Details of the CD4 levels (Figure S1), antibody affinity by
peptides (Figure S4), neutralization profile of each patient (Figure
S5) and virus load (Figure S6) can be found at supporting
information.
Selective Regimen
In order to gain deeper insights into the selective regimen of
HIV-1 during natural infection, a systematic codon-based analysis
was performed. According to the estimated likelihoods of each
model, the hypothesis of positive selection (which is based on the
Figure 1. Schematic representation of the blood-transmission cluster. Each column represents all samples of one patient. DO: donor; RA:
recipient A; RB: recipient B; SC: sexual partner of the RB. Gray rectangles indicate each time-point with sampling date, number of clones generated
and the mean of the pairwise diversity plus standard error. Filled circles indicate number of X4-variant sequences. Arrows indicate the date and the
transmission route.
doi:10.1371/journal.pone.0039776.g001
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and v2)) was widely accepted, with the exception to the data set
RB (1989–1990) (Table 1). The estimated parameters for the DO
clones sampled between 1985 and 1993 indicated that the overall
percentage of positively selected sites was 10% and the estimated
mean v value was 7.4. The M3 model also detected the codons 5,
33, 44 and 70 with high posterior probability ($0.99) of positive
selection in the fragment of env gene of HIV-1. Since the viral
population of recipient DO was composed by two distinct variants
(see the phylogenetic analysis above), they were analyzed
separately. The analysis of the dataset with molecular clones of
the GSGR variant sampled between 1987 and 1991 showed 6% of
Figure 2. Maximum a posteriori tree of the blood donor and the recipients. This tree was constructed using molecular clones of the donor
(DO) and the blood recipients. Sequences from all time points were included. The sampling time of clones are indicated in the sequences names (last
two digits). Highlighted areas designate clones isolated the late stages of infection. Numbers above the branches indicate the Bayesian posteriori
statistical support for the tree clades. A) The sequences of the donor DO are colored in magenta (GPGR variant) and in green (GSGR variants). The
sequences of the recipient RA are colored in orange. Branches colored in orange indicate viruses that spread over the infection time in the RA. B) All
clones generated from 1987 to 1990 from the HIV infection of the recipient RB were also included. The sequences of the recipient RB are colored in
blue. The blue branches indicate viruses that spread over time in the RB. The red branches in the tree indicate the X4 variants.
doi:10.1371/journal.pone.0039776.g002
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44 was detected with high posterior probability (Table 1). The
other dataset with sequences of GPGR variants sampled between
1987 and 1991 detected the same proportion of 6% of sites
positively selected and the mean v value was also 13, the codons
33, 44 and 70 were detected with high posterior probability of
been under positive selection. Interestingly, codons 33 and 44
correspond respectively to codons 11 and 25 of V3 loop; which are
related with R5-to-X4 change in HIV-1.
The analysis of recipients’ sequences also revealed the presence
of positive selection in diversification of HIV-1. For RA dataset we
found 4% of codons under positive selection with mean v value of
5.5 (Table 1). In this case, only the codon 14 was detected with
high posterior probability of positive selection. Similarly, the
proportion of positively selected sites was 5.5% with a mean v
value of 6.9 for the dataset with all sequences of RB. Additionally,
the M3 model detected the codons 5, 7 and 44 with high posterior
probability of positive selection for RB sequences. Further
subdivisions were also made with the sequences of RB (Table 1)
where two time intervals were analyzed. First, sequences sampled
between 1986 and 1987 were analyzed. The result showed 12% of
positively selected codons with a mean v of 6.5 and the sites 5, 30
and 44 were detected with high posterior probability. Second,
another dataset with RB sequences sampled between 1989 and
1990 was also studied. In this case, model M2 (selection) was the
best fitted and indicated that 26% of sites were positively selected
with a mean v of 1.9, although the high posterior probability
indicated there are no codons under positive selection.
To better explore the observed reduction in the strength of
positive selection of RB viruses sampled between 1989 and 1990,
we used a branch-site model (see model D in methods for details).
This model permits to investigate if a specific part of a
Table 1. Maximum likelihood estimates of dN and dS using codon-based models.
Model ,=likelihood Parameters estimated 2D,
1 Positively selected sites
#
DO GP-variants (1985–1993)
: (n=42, l=228)
M0 (one-ratio) ,0=2837.29 v=0.734 87.419 Not allowed
M3 (discrete)
* ,1=2793.58 P0=0.697 p1=0.201 p2=0.102 v0=0.174
v1=1.211 v2=7.396
5, 33, 44, 70
DO GS-variants (1987–1991) (n=15, l=228)
M0 (one-ratio) ,0=2448.12 v=1.342 11.830 Not allowed
M3 (discrete)
* ,1=2442.20 P0=0.517 p1=0.422 p2=0.061 v0=0v1=2.187
v2=13.079
44
DO GP-variants (1987–1991) (n=14, l=228)
M0 (one-ratio) ,0=2590.25 v=0.967 61.264 Not allowed
M3 (discrete)
* ,1=2559.61 P0=0.831 p1=0.102 p2=0.067 v0=0.235
v1=1.173 v2=13.112
33, 44, 70
RA (1986–1991) (n=46, l=228)
M0 (one-ratio) ,0=2954.51 v=0.713 83.902 Not allowed
M3 (discrete)
* ,1=2912.53 P0=0.653 p1=0.311 p2=0.036 v0=0.057
v1=1.896 v2=5.537
14
RB (1986–1990)
: (n=58, l=228)
M0 (one-ratio) ,0=2947.89 v=0.922 123.677 Not allowed
M3 (discrete)
* ,1=2886.05 P0=0.631 p1=0.266 p2=0.102 v0=0.141
v1=1.490 v2=10.723
5, 7, 44
RB (1986–1987) (n=21, l=228)
M0 (one-ratio) ,0=2583.90 v=0.525 44.913 Not allowed
M3 (discrete)
* ,1=2559.45 P0=0.315 p1=0.570 p2=0.116 v0=0.000
v1=0.326 v2=6.511
5, 30, 44
RB (1989–1990)
: (n=23, l=228)
M0 (one-ratio) ,0=2772.86 v=0.718 29.160 Not allowed
M2 (selection)
$ ,1=2758.28 P0=0.577 p1=0.159 p2=0.263 v0=0.127
v1=1.000 v2=1.977
none
SC (1988–1990) (n=32, l=228)
M0 (one-ratio) ,0=2796.11 v=1.651 143.48 Not allowed
M3 (discrete)
* ,1=2759.40 P0=0.550 p1=0.321 p2=0.129 v0=0.002
v1=2.292 v2=9.076
15, 44, 48, 60, 70
1)Assuming that M0 is true null hypothesis (G0) with p0 parameters and that M3 is the alternative hypothesis (G1) with p1 parameters. The log likelihood difference
2D,=2(,12,0) follows asymptotically a x
2 distribution with (p12p0) degrees of freedom.
*)Best-fitted model according to the likelihood ratio test (LRT) between of M0 vs. M3 with 4 degrees of freedom.
$)Best-fitted model according to the likelihood ratio test (LRT) between of M2 vs. M3 with 1 degree of freedom.
#)Positively selected sites were detected according to the Naive Empirical Bayes method with p$0.99. Sites 33 and 44 (underlined) correspond respectively to sites 11
and 25 of V3 loop; which are related with R5-to-X4 change.
:)This result was obtained using unique sequences and X4-strains because exclusion of them did not affect on the model preference or the parameter values.
doi:10.1371/journal.pone.0039776.t001
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branches of the tree [25]. We used unique sequences sampled from
RB between 1986 and 1990 and investigated if some branches
(depicted in colors in the Figure 3) would have sites with distinct
selective pressures. Results indicate that sequences isolated in 1990
evolve distinctively than those sequences isolated before this time
point according to LRT (x
2=6.759926, p=0.009). Overall, the
model detected 47% of sites under strong purifying selection
(v=0.042) and 41% of neutral (v=1). In addition, there is a set of
codons (>12%) under strong positive selection (v=11.0875) in
sequences isolated between 1986 and 1989. This set of codons
experienced reductions in the intensity of positive selection to
v=2.758 in sequences isolated in 1990 and to v=3.827 in the
cluster where X4 viruses emerged. This results indicate that
reductions in the intensity of positive selection is not restricted to
X4 sequences rather it is an overall feature of all sequences isolated
after 1990.
Lastly, for the dataset that included all sequences of the sexual
partner SC the model M3 identified 13% of sites under positive
selection with mean v of 9.0; the codons 15, 44, 48, 60 and 70
were detected high posterior probability of positive selection
(Table 1). It is noteworthy that codon 44 is related R5-to-X4
phenotype shift in HIV-1, this codon was under positive selection
in individuals DO and RB in both X4-variants were detected as
minor variant in the intra-host viral population. Codon 44 was
also under positive selection in the intra-host viral population of
individual SC, although X4-varints were not detected in this
patient.
Discussion
Since the first stages of HIV-1 infection might be crucial for the
characterization of viral diversity and the antibody response
against viral epitopes might be the leading force driving HIV
diversification in the initial phase of infection [1,2,3]. Thus, the
observation that monoclonal antibodies preferentially neutralize
X4 variants [26] might explain the initial advantage of R5 viruses.
However, it has been shown that recent emerged X4 variants are
more sensitive to antibody neutralization than late emerged X4
variants [27]. Consequently, X4 variants might effectively adapt to
escape from antibody neutralization and establish as new lineages
in the late stages of HIV infection. In addition, the HLA profile
would be insightful to the further understand the pattern of
selective pressure in the quasispecies within each patient,
unfortunately this information not available in our study. Of note,
X4 viruses observed within the recipient RB presented reduced
number of glycosylation sites compared to other variants, thus
suggesting that to infect host cell newly emerged X4 variants lessen
the protection of the ‘‘glycan shield’’. X4 viruses isolated in late
stages of RB infection maintained low levels of glycosylation,
making them more vulnerable to antibody neutralization.
Furthermore, it has been suggested that structural features of V3
loop might also constraint the R5-to-X4 shift within-hosts [28].
Thus, the background of the virus that initiates the infection might
also contribute to the appearance and establishing of X4 variants.
On the other hand, considering that HIV has extremely high
rates of adaptive mutations of HIV [29] and the emergence of X4
variants is associated with the acquisition of a reduced positively
charged amino acids in V3 loop [28,30,31]. Then, the selective
pressure imposed solely by antibody neutralization might partially
explain the late emergence of X4 viruses, but not the replacement
of R5 variants or the decline of CD4 levels associated with of X4
viruses. Our results showed relaxation of positive selection, in the
patient RB, occurred equally in X4 and R5 viruses. Consequently,
there is no evidence of distinct adaptive evolution between these
variants that would favor X4 variants to predominate in the
infection.
Our results also showed that appearance of distinct HIV viruses
occurs even when the overall diversity is low (i.e, GSGR variants).
Thus, the genetic divergence (measured by the pairwise diversity)
in the epidemic cluster has no relation to the dynamic process of
lineages replacement. The intra-host HIV population of the donor
DO was characterized by the emergence of GSGR variant two
years after initial infection. This less divergent strain was the main
variant between 1989 and 1991, while the GPGR strain (that
initiated the infection and was highly divergent) reappeared and
was the only variant detected in 1993. Although selective pressure
has been pervasive, including in V3 loop sites associated with R5-
to-X4 shift (Table 1), the pattern of X4 emergence was quite
distinct among the individuals of the epidemic cluster. Interest-
ingly, X4-strains were not detected in the viral population of the
recipient RA and in the sexual partner SC during the study. These
results suggest that although the genetic background of the virus is
important to determine the emergence of X4 strains, the cellular
environment of hosts might be the key factor to control the timing
of R5-to-X4 shift. Interestingly, the emergence of X4 strains in the
donor (DO) and recipient B (RB) coincided with the high peak of
overall pairwise diversity.
Although the patient RA was treated with zidovudine since
1988 and the patient RB started with zidovudine monotherapy in
1989, the pairwise diversity of HIV was not affected. Figure 1
shows that viruses within the patient RA presented low diversity
prior to the therapy, whereas viral diversity in the patient RB
continuously increased since 1987.
Detailed analysis, performed in an known HIV transmission
chain showed that trees inferred using the pol gene were unable to
rescue the real evolutionary history of the virus because the
appearance of convergent drug-associated mutations. On the
other hand, trees constructed using the env gene were not affected
by reverse-transcriptase and protease inhibitors [32]. The effect of
antiretroviral therapy on the HIV diversity is highly specific:
antiviral drug will increase the adaptive value of mutations that
confer resistance to the virus. In fact, codons associated with drug
resistance in the RT gene of HIV evolve under purifying selection
in absence of therapy and shift to positive selection when therapy
initiates, while the overall intensity of selective pressure remained
unchanged [33].
It has been observed that selective pressure declines over time in
the intra-host HIV-1 population [4,5]. Previously, we found that
intensity of positive selection in HIV-1 is directly related with the
number of CD4+ cell [6]. Lemey et al. 2007, noticed an increase
in the rate of neutral mutations associated with disease progression
and suggested it was affected by the rate of HIV-1 replication (viral
generation time). It is noteworthy that the increasing diversity
detected in 1989 in the recipient RB coincides with the severe
decline of CD4+ T cell counts. This reduction of CD4 cells might
indicate loss of integrity of the immune system to mount response
directed to new viral epitopes. In this regard is tempting to suppose
that relaxation of immune pressure creates an ideal cellular
environment that increases the changes of newly emerged variants
not to be eliminated from intra-host viral population. The
replication rate observed in the patient RB coincide with the
possibility that elevated rate of naı ¨ve cells divisions facilitate X4
overgrowth [21] and provide further support to the importance of
host cellular environment to the dynamics of R5-to-X4 shift.
Indeed, random processes are likely to define HIV variants that
will prevail in the viral population of recently infected individuals
[8].
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39776Figure 3. Adaptive evolution during the natural HIV-1 infection. A maximum likelihood tree was inferred with unique V3 region sequences of
the blood recipient RB. Branch-site model was used to evaluate if specific regions (clusters corresponding to distinct chronological times) of the tree
were under distinct selective pressures. The tree depicts selective pressures (dN/dS) in distinct moments (years) of HIV-1 infection. The ratio dN/dS
was estimated in isolates sampled from 1986 to 1989 (blue branches), then in isolates from 1989 to 1990 (pink branches) and finally in the cluster
where X4 viruses appeared (red branches, X4 variants are indicated by arrows within this cluster). Dotted lines delineate each group of sequences
where (dN/dS) was estimated. The last two digits in each name designate the year that a specific sequence was sampled. The panel in the bottom of
the figure shows the estimated parameters of model M3 (null hypothesis) and model D (alternative hypothesis) (see the manuscript for details).
doi:10.1371/journal.pone.0039776.g003
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evolution within host is a complex process that might involves
subtle equilibrium between adaptation to the cellular environ-
ment, escape of the immune response and perhaps random
fixation of variants. By using pairwise distances and branch-site
models we showed that HIV-1 diversity in the late stages of
infection increases and positive selection is relaxed. It is likely that
the observed increase in diversity occurred due to the accumu-
lation of neutral mutations. Although the decline of positive
selection and the increase in of genetic diversity observed in the
late stages of HIV-1 infection have been associated with humoral
immune response [1,4,5]. Here we show varying levels of humoral
immune response over infection time had little impact to HIV
diversity, however reduction of CD4+ T cells counts is the main
cause of the low intensity of positive selection.
Materials and Methods
Ethics statement
This study was approved by the Ethics Committee of the
Federal University of Sa ˜o Paulo and by the Brazilian Ministry
Health; all biological samples were obtained in full accordance
with signed informed consent forms.
Sequences and data set compilation
All sequences used in this study were generated in a previous
study [34]. Briefly, viral RNA from plasma was used to generate
molecular clones by limiting dilution PCR from viruses isolated
from distinct time-point, these sequences were from a 231-bp
fragment of envelope (env) gene from HIV-1 subtype B. A total of
200 clones (156 unique sequences) were generated, they were from
an epidemic cluster composed by the donor (DO); two blood
recipients (RA, RB) and one individual infected by one of the
recipient by sexual contact (SC). These individuals were not
exposed to antiviral drug during the time interval of the study, thus
the mutation pattern of the sequences represent the natural
evolution of HIV in its host. The transition route and the
samplings time are schematically represented in the figure 1. The
alignment contained all sequences used can be obtained at http://
www.biotorrents.net/.
Sequence alignment
The sequences were initially aligned using the ClustalX
program [35], then sites with deletions and insertions were then
excluded in order to preserve the reading frames of the genes.
After this editing process, the sequences were manually aligned
using the SE-AL program, version 2.0 (Department of Zoology,
Oxford University; http://evolve.zoo.ox.ac.uk/software/). To
compute pairwise distances we used the Kimura two-parameters
model, the estimates were performed using the Mega software
version 4.0 [36]
Proportion of N-linked glycosylation sites
The N-linked glycosylation sites were determined by identifying
the NX[ST]Y pattern (where X can be any amino acid). Amino
acids, such as proline, in the X or Y position can be important
determinants of N-linked glycosylation efficiency [37]. The
analyses were performed using the web interface available at
http://www.hiv.lanl.gov/content/hiv-db/GLYCOSITE/
glycosite.html.
Phylogenetic inference
To construct the trees we used Bayesian methods, assuming
GTR and a gamma correction model, as is implemented in the
MrBayes program, version 3.1.2 [38]. Two independent Markov
chain Monte Carlo (MCMC) processes were run for 2610
7
generations with the initial 10% of each run discarded as burn-in.
The convergence of chains was evaluated using the TRACER
software, version 1.2 (http://beast.bio.ed.ac.uk/), and runs were
accepted when all parameters presented the effective sample size
number (ESS) greater than 100. Maximum posteriori (MP) trees
were show and edited using the FigTree software (http://tree.bio.
ed.ac.uk/software/figtree/).
Prediction of coreceptor usage
In addition to the presence of basic amino acids at sites 11 and
25 of the V3 loop (11/25 rule), the position-specific scoring
matrices (PSSM) method was also used in our analyses [39]. The
PSSM detects nonrandom distributions of amino acids in a set of
sequences that may be associated with some empirically
determined property (for example, coreceptor usage) and con-
structs a matrix. The matrix is then used to compare the amino
acids of query sequences and PSSM assigns scores to each query
sequence. Consequently, these scores can be used to predict the
likelihood of a query sequence having the property of interest. We
predicted the coreceptor usage of our sequences using a PSSM
matrix (x4r5) constructed with the V3 region of HIV-1 subtype B
with a known X4 or R5 phenotype (http://mullinslab.microbiol.
washington.edu/computing/pssm/). Results can be interpreted as
follow; high scoring sequences are more likely to use the CXCR4
coreceptor, while low scoring sequences are more likely to use the
CCR5 coreceptor.
Detection of selective pressure
Selective pressures were analyzed using an approach that
estimates the number of dN and dS at all sites in the sequence
alignments. The method compares the fit to the data of various
models of codon evolution, which differ in the distribution of dN/dS
(v) among codons and takes into account the phylogenetic
relationships of the sequences [40].
The model 0 (M0: one-ratio) assumes a single v for all codons in
the alignment and hence is the simplest model specified.
The model 1 (M1: neutral) allows different proportions of
conserved (v=0) and neutral codons (v=1), both estimated from
the data. The model 2 (M2: selection) has an additional class of
codons with its v ratio (which can be .1) estimated from the data.
The model 3 (M3: discrete) also allows positive selection by
incorporating three categories of codons with the v value at each
estimated from the data. Nested models can be compared using a
standard likelihood ratio test (LRT). Significant evidence for
positive selection is provided if M2, or more normally M3,
significantly reject the null hypothesis M0 and M1, and if the
favored models contain a class of codons where v.1. We also
used an extension of M3 to investigate if there are sites evolving
under different selective pressure, this model allow to detected sites
not necessarily under positive selection [25]. This model (model D
with k=3) was used to determine if a specific group of sequences
(i.e., sequences of recipient RB sampled in 1990) was subjected to a
distinct selective regimen in a phylogenetic tree constructed with
sequences sampled over the HIV-1 infection time in individual.
Since model D is nested to M3, we used LRT and M3 as the null
hypothesis assuming one degree of freedom. All these models are
implemented in the CODEML program from the PAML v. 3.14
package (http://abacus.gene.ucl.ac.uk/software/paml.html). To
the positive selection estimate molecular clones of each patient
were analyzed separately. Additional subdivisions of the intra-host
molecular clones were also made in order to obtain more detailed
information on a particular time interval. For example, sequences
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1985 and 1993. Then these sequences were subdivided into two
other datasets; one composed by HIV-1 variants with the GPGR
tetramer at the V3 loop of env gene and other composed by
variants with GSGR tetramer. These two datasets included clones
sampled between 1987 and 1991 because GSGR viruses emerged
after 1987 (see results).
Supporting Information
Figure S1 CD4+ T cell levels during HIV-1 infection. The
numbers of CD4+ T cells per mm3 of each time point of the
infection are represented by colored lines. Each line represents one
individual.
(TIFF)
Figure S2 Maximum a posteriori tree of the recipient
RB and the patient SC. This tree was constructed using
molecular clones of the recipient RB and her sexual partner SC.
Sequences from all time points were included. The sampling time
of clones are indicated in the sequences names (last two digits).
Numbers above the branches indicate the Bayesian posteriori
statistical support for the tree clades. A) The sequences of the
recipient RB are indicated in blue and in red colors (X4 variants).
The sequences of the patient SC are colored in orange. The tree
was rooted at the midpoint.
(TIFF)
Figure S3 Glycosylation pattern of the V3 loop of HIV-1.
Numbers above branches indicate glycosylated sites in the V3
region. The tree shows clones of within-host sequences of the
blood donor DO (depicted in pink color) and the recipients RA
(depicted in green) and RB (depicted in blue and red color for X4
isolates). Highlighted areas represent clusters of isolates obtained
from the last time points in each individual. The statistical support
of the tree is indicated by the colors of branches in a gradient scale
from yellow to red, respectively indicating posterior probability of
0.5 to 0.99. Some branches were collapsed to facilitate
visualization.
(TIFF)
Figure S4 Antibody affinity by autologous synthetic
peptides. The humoral immunity of each patient was measured
by the affinity of their antibody to recognize peptides based on
consensus sequences of virus isolated in distinct time points.
Affinity was measured independently in each individual in distinct
time points.
(TIFF)
Figure S5 Neutralization of the heterologous MN strain
of HIV-1. Humoral immune response against the MN strain of
HIV-1 was measured in the plasma of patients during the over the
infection time. Each line represent one individual and points are
the measured immune response detected in each year (x-axis).
(TIFF)
Figure S6 Virus load of each patient during infection
time. The x-axis represents the sampling time of the study. Y-axis
depicts the amount of viruses measured in RNA copies per ml of
plasma.
(TIFF)
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